Crohns Disease Treatment Market Share

Crohn’s Disease Treatment Market Share

The Crohn’s disease treatment industry is characterized by intense competition among key players aiming to expand their market presence. Leading companies are focusing on strategic initiatives such as mergers, acquisitions, and partnerships to strengthen their market position. These efforts are aimed at enhancing their product offerings, expanding their geographic reach, and investing in advanced technologies to strengthen their market presence.
 

Crohn’s Disease Treatment Market Companies

The company profile section includes both companies that have commercial drug available in the market as well as those that are onto clinical phase development. Prominent players operating in the Crohn’s disease treatment industry are as mentioned below:

• AbbVie Inc.
• Amgen Inc.
• AstraZeneca Plc
• Biogen
• Boehringer Ingelheim GmbH
• Bristol Myerr Squibb
• Eli Lilly and Company
• Janssen Pharmaceuticals (Johnson & Johnson)
• Merck & Co. Inc
• Novartis AG
• Pfizer, Inc.
• Salix Pharmaceuticals, Inc.
• Takeda Pharmaceutical Industries Limited
• Viatris Inc. (Mylan N.V.)